Executive Insights Series – Life Sciences Finances: Keys for Attracting Investment – From Series A to IPO

Sean McClain is the Founder & CEO of Absci, pioneering a new era of medicine at the intersection of AI and biology to design life-changing drugs.

Sean envisions a world where we move beyond managing symptoms by dramatically shrinking timelines, slashing costs, and ultimately redefining how lifesaving medicines are created to find cures by design.

From a 400 sq. ft. basement lab to an industry-leading biotech platform, his journey reflects a deep belief that the future of health lies in merging human ingenuity with machine intelligence.

Michael Fishback is the Executive Director in Life Sciences at JPMorganChase, a role they have held since 2024. Prior to this, Michael served as the Director of Venture Debt Lending at MUFG from 2021 to 2024 and held senior positions at Silicon Valley Bank and KeyBank Real Estate Capital. Their earlier career includes experience as a Vice President at Seattle Bank and various roles at Comerica Bank, showcasing a strong background in finance and banking. Michael earned both a Bachelor of Arts in Finance, International Business, and Spanish, and a Master of Business Administration from the University of Washington, Michael G. Foster School of Business.